Contact
searchSearch
HMP Global

Hair and Trichology Topic Center

Featured

Alopecia
News
Upadacitinib Shows Consistent Efficacy Across Alopecia Areata Subgroups, Including Pediatric and JAK-Refractory Patients
03/31/2026
Riya Gandhi, MA
Meta-analysis reveals robust SALT improvements regardless of age, dose, or prior JAK inhibitor exposure.
Meta-analysis reveals robust SALT improvements regardless of age, dose, or prior JAK inhibitor exposure.
Meta-analysis reveals robust...
03/31/2026
The Dermatologist
oral medicine
News
Oral Supplementation Enhances Hair Strength and Collagen VII Expression in Patients With Hair Loss
03/31/2026
Riya Gandhi, MA
Combined nutraceutical formulation shows measurable improvements in hair resistance and structural biomarkers over 90 days.
Combined nutraceutical formulation shows measurable improvements in hair resistance and structural biomarkers over 90 days.
Combined nutraceutical...
03/31/2026
The Dermatologist
News
Upadacitinib Shows Promising Efficacy in Pediatric Refractory Alopecia Areata With Favorable Safety Profile
03/30/2026
Riya Gandhi, MA
Retrospective data suggest meaningful hair regrowth and tolerability in children with severe, treatment-resistant alopecia areata.
Retrospective data suggest meaningful hair regrowth and tolerability in children with severe, treatment-resistant alopecia areata.
Retrospective data suggest...
03/30/2026
The Dermatologist
alopecia areata
News
Upadacitinib Drives Robust Hair Regrowth in Adolescents and Adults With Severe Alopecia Areata
03/30/2026
Riya Gandhi, MA
Phase 3 subgroup analysis shows significant scalp and facial hair regrowth with upadacitinib, with consistent safety across age groups.
Phase 3 subgroup analysis shows significant scalp and facial hair regrowth with upadacitinib, with consistent safety across age groups.
Phase 3 subgroup analysis shows...
03/30/2026
The Dermatologist
alopecia areata
News
Study Highlights Patient-Driven Risk Tolerance for Ritlecitinib in Severe Alopecia Areata
01/16/2025
Jessica Garlewicz
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the...
01/16/2025
The Dermatologist
alopecia areata
News
Impact of the Gut and Skin Microbiome in Alopecia
12/19/2023
Jessica Garlewicz
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the...
12/19/2023
The Dermatologist
alopecia areata
News
Treatment Preferences of Adults and Adolescents With Alopecia Areata
12/19/2023
Jessica Garlewicz
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the...
12/19/2023
The Dermatologist
alopecia areata
News
Reflectance Confocal Microscopy and Dermoscopy: Insights Into Linear Alopecia in Pediatric Patients
12/12/2023
Jessica Garlewicz
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the...
12/12/2023
The Dermatologist
alopecia areata
News
Possible Association Between Genetically Predicted Rheumatoid Arthritis and Alopecia Areata
12/12/2023
Jessica Garlewicz
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate...
12/12/2023
The Dermatologist
alopecia areata
News
Clinical Benefits of Baricitinib Therapy in Patients With Severe Alopecia Areata
11/30/2023
Jessica Garlewicz
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results...
11/30/2023
The Dermatologist
alopecia areata
News
Screening For Latent Infectious Disease in Patients With Alopecia Areata Before Using JAK Inhibitors
11/20/2023
Jessica Garlewicz
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the...
11/20/2023
The Dermatologist

Expert Insights

Dr Natasha Atanaskova Mesinkovska
Podcasts
Dr Natasha Atanaskova Mesinkovska on Alopecia Areata
05/16/2023
Natasha Atanaskova Mesinkovska, MD, PhD
In this exclusive interview, Dr Natasha Atanaskova Mesinkovska discussed her session on hair loss and treatment options for alopecia areata.
In this exclusive interview, Dr Natasha Atanaskova Mesinkovska discussed her session on hair loss and treatment options for alopecia areata.
In this exclusive interview, Dr...
05/16/2023
The Dermatologist
CH
Videos
How to Teach Families About Safe Hair Care for Skin of Color
01/17/2022
Candrice Heath, MD, FAAP, FAAD
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses...
01/17/2022
The Dermatologist
CH
Videos
Integrating Skin of Color Hair Care for Young Patients
01/09/2022
Candrice Heath, MD, FAAP, FAAD
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath,...
01/09/2022
The Dermatologist
Feature Story
Growing in Your Hair Practice
02/16/2021
Lauren Mateja
With the emphasis on emergent conditions and chronic disease management, dermatology sometimes overlooks the importance of hair. Patients who have seen a dermatologist may exhibit signs and symptoms of alopecia,...
With the emphasis on emergent conditions and chronic disease management, dermatology sometimes overlooks the importance of hair. Patients who have seen a dermatologist may exhibit signs and symptoms of alopecia,...
With...
02/16/2021
The Dermatologist
Feature Story
Treating Androgenetic Alopecia: A Review of Nonsurgical Options
07/15/2020
Androgenetic alopecia (AGA) is a common form of hair loss that affects an estimated 80 million Americans.1 In men, it can begin as early as the teen years and follows a characteristic pattern, and in women, AGA...
Androgenetic alopecia (AGA) is a common form of hair loss that affects an estimated 80 million Americans.1 In men, it can begin as early as the teen years and follows a characteristic pattern, and in women, AGA...
...
07/15/2020
The Dermatologist
Feature Story
Hair Loss Treatments: A Word of Caution
09/04/2008
More than 50% of the population of men in their 50s has cosmetically significant male pattern hair loss. No doubt, the pressure on individuals to look younger comes from all directions in our society.
More than 50% of the population of men in their 50s has cosmetically significant male pattern hair loss. No doubt, the pressure on individuals to look younger comes from all directions in our society.
More than 50% of the population...
09/04/2008
The Dermatologist
Cox
Videos
Neuromodulator Market Trends: New Toxins, Pricing, and Practice Strategy
05/22/2026
Sue Ellen Cox, MD; Riya Gandhi, MA
Dr Sue Ellen Cox discusses how clinicians can navigate the rapidly expanding neuromodulator market by balancing scientific differentiation, duration of effect, pricing, loyalty programs, and patient preference.
Dr Sue Ellen Cox discusses how clinicians can navigate the rapidly expanding neuromodulator market by balancing scientific differentiation, duration of effect, pricing, loyalty programs, and patient preference.
Dr Sue Ellen Cox discusses how...
05/22/2026
The Dermatologist
Baldwin
Videos
The Skin Microbiome: Dermatologic Insights
05/22/2026
Hilary E. Baldwin, MD; Riya Gandhi, MA
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how...
05/22/2026
The Dermatologist
clark
Videos
Insights Into Energy-Based Devices
05/22/2026
Patrick J. Clark, PhD; Riya Gandhi, MA
Patrick Clark, PhD, CMLSO, reviews the foundational principles behind safe and effective use of energy-based devices in dermatology, including wavelength, pulse duration, power, spot size, and target chromophore selection.
Patrick Clark, PhD, CMLSO, reviews the foundational principles behind safe and effective use of energy-based devices in dermatology, including wavelength, pulse duration, power, spot size, and target chromophore selection.
Patrick Clark, PhD, CMLSO,...
05/22/2026
The Dermatologist
Lain
Videos
Skin Longevity Skincare: Exosomes, PDRN, and Epigenetic Innovation
05/22/2026
Ted Lain, MD; Riya Gandhi, MA
Dr Ted Lain discusses emerging skincare innovations, including polynucleotides, exosomes, and epigenetic-targeting ingredients, and how they may shape the future of skin longevity.
Dr Ted Lain discusses emerging skincare innovations, including polynucleotides, exosomes, and epigenetic-targeting ingredients, and how they may shape the future of skin longevity.
Dr Ted Lain discusses emerging...
05/22/2026
The Dermatologist
Rajiv Nijhawan, MD
Videos
Perioperative Care: Antibiotics, Anticoagulants, Pain Control, and Anxiolysis
05/21/2026
Rajiv Nijhawan, MD; Riya Gandhi, MA
Dermatologic surgeons can often avoid unnecessary antibiotics and interruption of anticoagulants while optimizing outcomes through careful perioperative planning, multimodal pain management, and coordinated chemoprophylaxis strategies.
Dermatologic surgeons can often avoid unnecessary antibiotics and interruption of anticoagulants while optimizing outcomes through careful perioperative planning, multimodal pain management, and coordinated chemoprophylaxis strategies.
Dermatologic surgeons can often...
05/21/2026
The Dermatologist
Vishal Patel
Videos
Neoadjuvant and Adjuvant Immunotherapy in Skin Cancer: Key Updates
05/21/2026
Vishal A Patel, MD; Riya Gandhi, MA
Emerging evidence suggests neoadjuvant immunotherapy may improve outcomes and personalize treatment planning for patients with high-risk melanoma and cutaneous squamous cell carcinoma.
Emerging evidence suggests neoadjuvant immunotherapy may improve outcomes and personalize treatment planning for patients with high-risk melanoma and cutaneous squamous cell carcinoma.
Emerging evidence suggests...
05/21/2026
The Dermatologist
Mesinkovska
Videos
Metformin, GLP-1 Agonists, and Skin Longevity: Emerging Dermatologic Insights
05/20/2026
Natasha Atanaskova Mesinkovska, MD, PhD; Riya Gandhi, MA
Dr Natasha Mesinkovska explores how metformin and GLP-1 receptor agonists may influence skin aging, pigmentation, wound healing, and longevity pathways.
Dr Natasha Mesinkovska explores how metformin and GLP-1 receptor agonists may influence skin aging, pigmentation, wound healing, and longevity pathways.
Dr Natasha Mesinkovska explores...
05/20/2026
The Dermatologist
Masterclasses in Dermatology Saturday Morning Live
Podcasts
New Targets for Atopic Dermatitis and Chronic Itch: Neuroimmune Biology, OX40, JAK Inhibitors, and What's Coming
05/20/2026
Joseph F. Merola, MD, MMSc; Alice Bendix Gottlieb, MD, PhD
Dr Shawn Kwatra joins hosts Dr Joseph Merola and Dr Alice Gottlieb to break down the neuroimmune biology of chronic itch, why pruritus persists even after skin clears, and what to do about it in your next clinic.
Dr Shawn Kwatra joins hosts Dr Joseph Merola and Dr Alice Gottlieb to break down the neuroimmune biology of chronic itch, why pruritus persists even after skin clears, and what to do about it in your next clinic.
Dr Shawn Kwatra joins hosts Dr...
05/20/2026
The Dermatologist
Masterclasses in Dermatology Saturday Morning Live
Podcasts
Cardiodermatology and Cardiovascular Risk in Inflammatory Skin Disease
05/20/2026
Joseph F. Merola, MD, MMSc; Alice Bendix Gottlieb, MD, PhD
Dr Joseph Merola and Dr Alice Gottlieb are joined by Dr Brittany Weber, one of the first cardiodermatologists in the United States, to lay out the clinical case for owning cardiovascular risk assessment in inflammatory skin disease.
Dr Joseph Merola and Dr Alice Gottlieb are joined by Dr Brittany Weber, one of the first cardiodermatologists in the United States, to lay out the clinical case for owning cardiovascular risk assessment in inflammatory skin disease.
Dr Joseph Merola and Dr Alice...
05/20/2026
The Dermatologist
Allen
Videos
Multimodal Biostimulation in Dermatology: PDGF-BB, Hyperdilute CaHA, and Microneedling
05/20/2026
Sarah L. Allen, MD; Riya Gandhi, MA
Dr Sarah Allen discusses the science behind combining PDGF-BB, hyperdilute calcium hydroxylapatite, and microneedling to improve cellulite, striae, and skin laxity through regenerative biostimulation.
Dr Sarah Allen discusses the science behind combining PDGF-BB, hyperdilute calcium hydroxylapatite, and microneedling to improve cellulite, striae, and skin laxity through regenerative biostimulation.
Dr Sarah Allen discusses the...
05/20/2026
The Dermatologist

News

alopecia areata
News
Study Highlights Patient-Driven Risk Tolerance for Ritlecitinib in Severe Alopecia Areata
01/16/2025
Jessica Garlewicz
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the...
01/16/2025
The Dermatologist
alopecia areata
News
Impact of the Gut and Skin Microbiome in Alopecia
12/19/2023
Jessica Garlewicz
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the...
12/19/2023
The Dermatologist
alopecia areata
News
Treatment Preferences of Adults and Adolescents With Alopecia Areata
12/19/2023
Jessica Garlewicz
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the...
12/19/2023
The Dermatologist
alopecia areata
News
Reflectance Confocal Microscopy and Dermoscopy: Insights Into Linear Alopecia in Pediatric Patients
12/12/2023
Jessica Garlewicz
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the...
12/12/2023
The Dermatologist
alopecia areata
News
Possible Association Between Genetically Predicted Rheumatoid Arthritis and Alopecia Areata
12/12/2023
Jessica Garlewicz
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate...
12/12/2023
The Dermatologist
alopecia areata
News
Clinical Benefits of Baricitinib Therapy in Patients With Severe Alopecia Areata
11/30/2023
Jessica Garlewicz
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results...
11/30/2023
The Dermatologist
alopecia areata
News
Screening For Latent Infectious Disease in Patients With Alopecia Areata Before Using JAK Inhibitors
11/20/2023
Jessica Garlewicz
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the...
11/20/2023
The Dermatologist
alopecia areata
News
Utilizing Autologous Adipose Tissue Injection in Alopecia Treatment
11/17/2023
Jessica Garlewicz
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the...
11/17/2023
The Dermatologist
alopecia areata
News
Association Between Zinc Deficiency and Alopecia Areata
11/16/2023
Jessica Garlewicz
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for...
11/16/2023
The Dermatologist
alopecia areata
News
Links Between Alopecia Areata and Auditory Dysfunction
10/23/2023
Jessica Garlewicz
Researchers aimed to investigate the link between alopecia areata and hearing problems.
Researchers aimed to investigate the link between alopecia areata and hearing problems.
Researchers aimed to investigate...
10/23/2023
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
FDA Alerts
FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients
03/18/2026
Jessica Garlewicz
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug...
03/18/2026
The Dermatologist
FDA Alerts
FDA Approves Cosentyx for the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate-To-Severe Hidradenitis Suppurativa
03/17/2026
Jessica Garlewicz
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug...
03/17/2026
The Dermatologist
AD
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
FDA Alerts
FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis
03/10/2026
Jessica Garlewicz
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food...
03/10/2026
The Dermatologist
random
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
Cutaneous Squamous Cell Carcinoma
News
Managing Cutaneous Squamous Cell Carcinoma
01/06/2026
Jessica Garlewicz
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review...
01/06/2026
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Roflumilast Cream 0.05% for Treatment of Atopic Dermatitis in Children Aged 2 to 5
10/06/2025
Riya Gandhi, MA
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA...
10/06/2025
The Dermatologist

Quizzes and Polls

Quiz
Trivia: Alopecia Areata
03/29/2019
Which finding is common among patients with alopecia areata affecting the nails?
Which finding is common among patients with alopecia areata affecting the nails?
Which finding is common among...
03/29/2019
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist
Quiz
Early Intervention Strategies in Pediatric Atopic Dermatitis
02/26/2026
Riya Gandhi, MA
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of...
02/26/2026
The Dermatologist
April/May 2026 cover

Current Issue

May 2026
Volume 34
Issue 3
Current Issue
Issue Archive

Recent News

alopecia areata
News
Study Highlights Patient-Driven Risk Tolerance for Ritlecitinib in Severe Alopecia Areata
01/16/2025
Jessica Garlewicz
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the...
01/16/2025
The Dermatologist
alopecia areata
News
Impact of the Gut and Skin Microbiome in Alopecia
12/19/2023
Jessica Garlewicz
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the...
12/19/2023
The Dermatologist
alopecia areata
News
Treatment Preferences of Adults and Adolescents With Alopecia Areata
12/19/2023
Jessica Garlewicz
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the...
12/19/2023
The Dermatologist
alopecia areata
News
Reflectance Confocal Microscopy and Dermoscopy: Insights Into Linear Alopecia in Pediatric Patients
12/12/2023
Jessica Garlewicz
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the...
12/12/2023
The Dermatologist
alopecia areata
News
Possible Association Between Genetically Predicted Rheumatoid Arthritis and Alopecia Areata
12/12/2023
Jessica Garlewicz
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate...
12/12/2023
The Dermatologist
alopecia areata
News
Clinical Benefits of Baricitinib Therapy in Patients With Severe Alopecia Areata
11/30/2023
Jessica Garlewicz
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results...
11/30/2023
The Dermatologist
alopecia areata
News
Screening For Latent Infectious Disease in Patients With Alopecia Areata Before Using JAK Inhibitors
11/20/2023
Jessica Garlewicz
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the...
11/20/2023
The Dermatologist
alopecia areata
News
Utilizing Autologous Adipose Tissue Injection in Alopecia Treatment
11/17/2023
Jessica Garlewicz
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the...
11/17/2023
The Dermatologist
alopecia areata
News
Association Between Zinc Deficiency and Alopecia Areata
11/16/2023
Jessica Garlewicz
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for...
11/16/2023
The Dermatologist
alopecia areata
News
Links Between Alopecia Areata and Auditory Dysfunction
10/23/2023
Jessica Garlewicz
Researchers aimed to investigate the link between alopecia areata and hearing problems.
Researchers aimed to investigate the link between alopecia areata and hearing problems.
Researchers aimed to investigate...
10/23/2023
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
FDA Alerts
FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients
03/18/2026
Jessica Garlewicz
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug...
03/18/2026
The Dermatologist
FDA Alerts
FDA Approves Cosentyx for the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate-To-Severe Hidradenitis Suppurativa
03/17/2026
Jessica Garlewicz
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug...
03/17/2026
The Dermatologist
AD
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
FDA Alerts
FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis
03/10/2026
Jessica Garlewicz
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food...
03/10/2026
The Dermatologist
random
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
Cutaneous Squamous Cell Carcinoma
News
Managing Cutaneous Squamous Cell Carcinoma
01/06/2026
Jessica Garlewicz
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review...
01/06/2026
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Roflumilast Cream 0.05% for Treatment of Atopic Dermatitis in Children Aged 2 to 5
10/06/2025
Riya Gandhi, MA
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA...
10/06/2025
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use